Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

445
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
445

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metal-Drug Complexes as Long-Release Application for Antimalarial PfFNT-Inhibitors.

ChemMedChem·2026
Same author

Aortic asprosin overexpression does not ameliorate disease pathophysiology in a murine model of Marfan syndrome.

Scientific reports·2026
Same author

Rethinking freezing: the misconception of nucleation temperature and ice crystal formation in freeze-drying.

International journal of pharmaceutics·2026
Same author

Nasal application of spray-dried powders - the impact of filling processes on deposition in a nasal cast.

International journal of pharmaceutics·2026
Same author

Systematic optimisation of carrier particle geometry in interactive powder mixtures via a parametric design approach using Bayesian optimisation.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs.

Pharmaceutics·2025

Related Experiment Video

Updated: Oct 1, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.9K

Particle engineering in dry powders for inhalation.

Regina Scherließ1, Simon Bock1, Nicholas Bungert1

  • 1Department of Pharmaceutics and Biopharmaceutics, Kiel University, Grasweg 9a, 24118 Kiel, KiNSIS Priority Research Area, Kiel University.

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|March 6, 2022
PubMed
Summary

Particle engineering enhances dry powder inhalation (DPI) formulations for improved respiratory drug delivery. This review details particle engineering techniques for carrier-based and carrier-free systems, exploring future additive manufacturing applications.

Keywords:
Pulmonary drug deliveryadditive manufacturingcarrier engineeringmicroparticlesnanocrystalsnanoparticles

More Related Videos

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.8K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

1.0K

Related Experiment Videos

Last Updated: Oct 1, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.9K
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.8K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

1.0K

Area of Science:

  • Pharmaceutical Sciences
  • Biotechnology
  • Materials Science

Background:

  • Inhalation drug delivery offers advantages for respiratory and systemic diseases.
  • Dry powder inhalation (DPI) is a promising but challenging drug delivery method.
  • Current DPI formulations face limitations in drug delivery efficiency and targeting.

Purpose of the Study:

  • To review particle engineering as a formulation technique for pulmonary drug delivery.
  • To explore methods for optimizing existing DPI strategies and developing new ones.
  • To discuss carrier-based and carrier-free technologies for inhalation.

Main Methods:

  • Comprehensive review of particle engineering techniques for DPI.
  • Analysis of carrier attributes and modification methods.
  • Examination of nanocrystal, nanoparticle, and carrier-free technologies.
  • Discussion of additive manufacturing for future carrier engineering.

Main Results:

  • Particle engineering offers solutions to improve DPI formulation efficacy and safety.
  • Various techniques exist for modifying carrier attributes or manufacturing desired carriers.
  • Nanocrystal, nanoparticle, and carrier-free technologies show potential for advanced applications.
  • Additive manufacturing presents future opportunities in carrier engineering.

Conclusions:

  • Particle engineering is crucial for advancing pulmonary drug delivery via DPI.
  • Diverse particle engineering approaches can overcome current formulation challenges.
  • Future innovations, including additive manufacturing, will further enhance inhalation therapies.